RE:RE:The real numbers behind Aimia revealed I believe they are at least considering selling the Cardlytics stake.
With Cardlytics filing an S-3 which includes up to 4M shares to be sold by insiders, and Rabe's conference call comment that they will "continue to monitor" the investment, it seems that they are at least preparing for the possibility. The max price for shares sold is $27.02 according to the S-3, so they may have to file again to increase that price, given the significant increase. The stock is volatile so hopefully they don't miss an opportunity to sell into strength.